Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $87.1100 (1.37%) ($87.1100 - $88.2500) on Sat. Oct. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 54 | Latest Price | $87.1100(1.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.5% a day on average for past five trading days. | Weekly Trend | LGND declines -1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting LGND price | LGND will decline at least -1.395% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $89.69 | 5 Day Moving Average | $90.03(-3.24%) | 10 Day Moving Average | $90.8(-4.06%) | 20 Day Moving Average | $89.69(-2.88%) | To recent high | -19.1% | To recent low | 12.2% | Market Cap | $N/A | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |